Understanding GWI: Integrative Modeling
Conditions: Gulf War Illness; Persian Gulf Syndrome; Occupational Diseases Interventions: Drug: Etanercept; Drug: Mifepristone Sponsors: South Florida Veterans Affairs Foundation for Research and Education; Nova Southeastern University; United States Department of Defense Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2020 Category: Research Source Type: clinical trials
Tumor Necrosis Factor (TNF) and Glucocorticoid Antagonist for Gulf War Illness (GWI)-Associated Multi-symptom Disease Homeostasis Reset
Condition: Gulf War Illness Interventions: Drug: Etanercept; Drug: Mifepristone Sponsors: Nova Southeastern University; RTI International; Rochester General Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2020 Category: Research Source Type: clinical trials
Understanding GWI: Integrative Modeling
Conditions: Gulf War Illness; Persian Gulf Syndrome; Occupational Diseases Interventions: Drug: Etanercept; Drug: Mifepristone Sponsors: South Florida Veterans Affairs Foundation for Research and Education; Nova Southeastern University; United States Department of Defense Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2020 Category: Research Source Type: clinical trials
Tumor Necrosis Factor (TNF) and Glucocorticoid Antagonist for Gulf War Illness (GWI)-Associated Multi-symptom Disease Homeostasis Reset
Condition: Gulf War Illness Interventions: Drug: Etanercept; Drug: Mifepristone Sponsors: Nova Southeastern University; RTI International; Rochester General Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2020 Category: Research Source Type: clinical trials
Understanding GWI: Integrative Modeling
Conditions: Gulf War Illness; Persian Gulf Syndrome; Occupational Diseases Interventions: Drug: Etanercept; Drug: Mifepristone Sponsors: South Florida Veterans Affairs Foundation for Research and Education; Nova Southeastern University; United States Department of Defense Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2020 Category: Research Source Type: clinical trials
Tumor Necrosis Factor (TNF) and Glucocorticoid Antagonist for Gulf War Illness (GWI)-Associated Multi-symptom Disease Homeostasis Reset
Condition: Gulf War Illness Interventions: Drug: Etanercept; Drug: Mifepristone Sponsors: Nova Southeastern University; RTI International; Rochester General Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2020 Category: Research Source Type: clinical trials
Understanding GWI: Integrative Modeling
Conditions: Gulf War Illness; Persian Gulf Syndrome; Occupational Diseases Interventions: Drug: Etanercept; Drug: Mifepristone Sponsors: South Florida Veterans Affairs Foundation for Research and Education; Nova Southeastern University; United States Department of Defense Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2020 Category: Research Source Type: clinical trials
Tumor Necrosis Factor (TNF) and Glucocorticoid Antagonist for Gulf War Illness (GWI)-Associated Multi-symptom Disease Homeostasis Reset
Condition: Gulf War Illness Interventions: Drug: Etanercept; Drug: Mifepristone Sponsors: Nova Southeastern University; RTI International; Rochester General Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2020 Category: Research Source Type: clinical trials
Understanding GWI: Integrative Modeling
Conditions: Gulf War Illness; Persian Gulf Syndrome; Occupational Diseases Interventions: Drug: Etanercept; Drug: Mifepristone Sponsors: South Florida Veterans Affairs Foundation for Research and Education; Nova Southeastern University; United States Department of Defense Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2020 Category: Research Source Type: clinical trials
Tumor Necrosis Factor (TNF) and Glucocorticoid Antagonist for Gulf War Illness (GWI)-Associated Multi-symptom Disease Homeostasis Reset
Condition: Gulf War Illness Interventions: Drug: Etanercept; Drug: Mifepristone Sponsors: Nova Southeastern University; RTI International; Rochester General Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2020 Category: Research Source Type: clinical trials
Understanding GWI: Integrative Modeling
Conditions: Gulf War Illness; Persian Gulf Syndrome; Occupational Diseases Interventions: Drug: Etanercept; Drug: Mifepristone Sponsors: South Florida Veterans Affairs Foundation for Research and Education; Nova Southeastern University; United States Department of Defense Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2020 Category: Research Source Type: clinical trials
Tumor Necrosis Factor (TNF) and Glucocorticoid Antagonist for Gulf War Illness (GWI)-Associated Multi-symptom Disease Homeostasis Reset
Condition: Gulf War Illness Interventions: Drug: Etanercept; Drug: Mifepristone Sponsors: Nova Southeastern University; RTI International; Rochester General Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2020 Category: Research Source Type: clinical trials
Understanding GWI: Integrative Modeling
Conditions: Gulf War Illness; Persian Gulf Syndrome; Occupational Diseases Interventions: Drug: Etanercept; Drug: Mifepristone Sponsors: South Florida Veterans Affairs Foundation for Research and Education; Nova Southeastern University; United States Department of Defense Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2020 Category: Research Source Type: clinical trials
A Retrospective Cohort Study on the Risk of Serious Infections in Rheumatoid Arthritis Patients Receiving Tocilizumab
Conditions: Infection; Rheumatoid Arthritis Interventions: Drug: Tocilizumab; Drug: Tumor Necrosis Factor Inhibitor (etanercept, infliximab, adalimumab, and golimumab) Sponsors: Sungkyunkwan University; Ministry of Food and Drug Safety, Korea Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 4, 2019 Category: Research Source Type: clinical trials
